Subscribe
shutterstock-201195872-1-edit
Peter Hermes Furian / Shutterstock.com
25 July 2016Americas

Deadly counterfeits entering US drug market, report says

The US Drug Enforcement Administration (DEA) has claimed that hundreds of thousands of counterfeit pills containing deadly substances have entered the US drug market.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Fake botox seized in Cincinnati
31 July 2020   US authorities have seized thousands of dollars worth of counterfeit Botox injections in shipments in a Cincinnati port, the US Customs and Border Protection (CBP) office announced yesterday, July 30.


Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024
Unified Patent Court
Does the UPC offer a fresh take on patent validity?
5 September 2024

More on this story

Americas
Fake botox seized in Cincinnati
31 July 2020   US authorities have seized thousands of dollars worth of counterfeit Botox injections in shipments in a Cincinnati port, the US Customs and Border Protection (CBP) office announced yesterday, July 30.

More on this story

Americas
Fake botox seized in Cincinnati
31 July 2020   US authorities have seized thousands of dollars worth of counterfeit Botox injections in shipments in a Cincinnati port, the US Customs and Border Protection (CBP) office announced yesterday, July 30.

More features

President Trump 2.0: Five major areas to watch
Startup CFO’s betrayal is a lesson in preparing for the worst
Sandoz lands reduced antitrust award of $70m
New president’s to-do list: Patent bills, non-competes, USPTO director?
Sanofi subsidiary fends off $450m trade secrets case
Regulatory expert joins White & Case
Teva faces $500m fine for antitrust breaches over MS drug
UK Budget: A missed opportunity?